Most Alzheimer's Patients Wouldn't Have Qualified for Controversial Drug's Trial: Study
Steven ReinbergTUESDAY, Sept. 14, 2021 (HealthDay News) -- U.S. approval of the Alzheimer's drug Aduhelm is already mired in controversy. Now a new study finds that most Alzheimer's patients could not have taken part in clinical trials that led to the green light.
In June, the U.S. Food and Drug Administration gave accelerated approval to Aduhelm (aducanumab) for treating patients with mild cognitive impairment or mild dementia from Alzheimer's disease.
The decision quickly came under fire because of the Biogen drug's high price -- $56,000 a year -- and questions about possible collaboration between regulators and the drug's maker.
Now, this new study points to other limitations.
The phase 3 trials of the drug showed an increased risk of certain adverse vascular events. Although the trials excluded elderly patients, those with certain chronic diseases and those using blood thinners, the FDA approved use of the drug in these patient populations without noting any precautions.
"Our findings are concerning given the broad FDA labeling for aducanumab," said researcher Dr. Timothy Anderson, an assistant professor of medicine at Beth Israel Lahey Health in Boston.
"The public conversation on aducanumab has focused on limited benefit and high costs. It is equally important to consider that the majority of patients with Alzheimer's disease are likely to face higher risks of adverse events than the patients studied in the trials," Anderson said in a health system news release.
For the study, the researchers looked at Medicare claims among 27 million patients with either cognitive (mental) impairment, Alzheimer's disease or Alzheimer's disease-related disorders.
They found that most of these patients had one or more conditions that would have banned them from the aducanumab clinical trials, including cardiovascular disease, stroke, use of blood thinners, or being over 85.
For example, data showed that about 9 out of 10 patients with Alzheimer's disease-related dementia or Alzheimer's disease itself had at least one factor that would have excluded them from the trials. Similarly, 85% of patients with cognitive impairment had at least one disqualifying condition.
And more than three-quarters of those with Alzheimer's disease-related dementia had several of these disqualifiers, the researchers noted.
"Clinical trials of aducanumab studied relatively healthy participants who do not reflect the majority of older adults with dementia in the U.S.," Anderson said. "As a result, Medicare should consider restricting coverage for aducanumab to patients who meet the trial eligibility criteria."
He said additional clinical trials of the high-risk groups excluded from the prior trials should be required and include rigorous study of adverse events.
The report was published Sept. 14 in the Journal of the American Medical Association.
In July, it was reported that two Congressional committees were looking into the process that led to the drug's approval and its steep cost. Although an FDA advisory committee concluded there wasn't enough evidence to support the effectiveness of Aduhelm, the FDA approved it. Three of the advisory committee members then resigned.
More information
For more on Alzheimer's disease, see the Alzheimer's Association.
SOURCE: Beth Israel Lahey Health, news release, Sept. 14, 2021
This article: Copyright © 2021 HealthDay. All rights reserved.
Resources
-
Articles
- Introduction & Causes of Cognitive Disorders
- Dementia
-
Alzheimer's Disease
- Alzheimer's Disease
- Prevalence and Causes of Alzheimer's Disease
- Causes of Alzheimer's Disease Continued
- Risk Factors for Alzheimer's Disease
- Symptoms of Alzheimer's Disease
- Warning Signs of Alzheimer's Disease
- Diagnosis of Alzheimer's Disease
- Diagnosis of Alzheimer's Disease - Imaging Procedures and Psychological Evaluation
- Diagnosis of Alzheimer's Disease - Neuropsychological Testing
- Treatment of Cognitive and Behavioral Symptoms associated with Alzheimer's Disease
- Research and Prognosis on Alzheimer's Disease
-
Other Cognitive Disorders
- Vascular Neurocognitive Disorder
- Vascular Neurocognitive Disorder Continued
- Lewy Body Dementia
- Symptoms of Lewy Body Dementia
- Diagnosis and Treatment of Lewy Body Dementia
- Reversible Cognitive Disorder - Dementia Syndrome of Depression
- Neurocognitive Disorder Due to Another Medical Condition
- Reversible Cognitive Disorder - Delirium
- Prevention of Dementia and Other Cognitive Disorders
-
Dementia Coping Skills & Behavior Management
- Coping Skills for Those With Dementia
- Coping Skills for Dementia Caregivers
- Services for Dementia Caregivers
- Communication Tips for Dementia Caregivers
- Behavioral Management for Dementia Caregivers
- Behavioral Management for Dementia Caregivers Continued
- Tips for Dealing with Specific Dementia Problematic Behaviors
- Tips for Dealing with Specific Dementia Problematic Behaviors Continued
- Traumatic Brain Injury (TBI)
- Conclusion and Resources
-
News
-
Questions and Answers
-
Book & Media Reviews
- Alive with Alzheimer's
- Alzheimer's
- Days With My Father
- Decision Making, Personhood and Dementia
- Dementia
- Dementia Caregivers Share Their Stories
- Hearing the Person With Dementia
- How We Think About Dementia
- Inside Assisted Living
- Mild Cognitive Impairment and Early Alzheimer's Disease
-
16 more
- Mom's OK, She Just Forgets
- My Book about Brains, Change and Dementia
- Nothing about us, without us!
- Remembering Home
- Rights, Risk and Restraint-Free Care of Older People
- Speaking Our Minds: Revised Edition
- Still Alice
- Telling Tales About Dementia
- The Almost Moon
- The Emotional Journey of the Alzheimer's Family
- The Enduring Self in People with Alzheimer's
- The Story of My Father
- Voices Of Alzheimer's
- When It Gets Dark
- When Someone You Know Is Living in a Dementia Care Community
- Wrinkles
-
Links
-
Videos
- Overview of Dementia with Lewy Bodies
- Common Challenges: Driving
- Diagnosis and Management of Vascular Dementia
- Difference Between Alzheimer's and Dementia
- Why Early Detection of Alzheimer’s Disease Matters
- Looking Beyond Alzheimer’s Disease: An Overview of Other Major Forms of Neurodegenerative Disease
- New Definition of Alzheimer’s Changes How Disease Is Researched
- Lewy Body Dementia: Most Common Disorder You’ve Never Heard Of
- Living With Traumatic Brain Injury
- Early Detection of Alzheimer's Disease
-
37 more
- Seeing Alzheimer's in a New Way
- Inside Alzheimer’s disease
- Alzheimer's Screening
- Neurology: Testing for Alzheimer's
- Alzheimer's and Dementia Caregiver Training: Sexually Inappropriate Behaviors
- Alzheimer's and Dementia Caregiver Training: Depression/Apathy
- Alzheimer's and Dementia Caregiver Training: Agitation and Anxiety
- Alzheimer's and Dementia Caregiver Training: Aggressive Language/Behavior
- Alzheimer's and Dementia Caregiver Training: Sleep Disturbances
- Alzheimer's and Dementia Caregiver Training: Repetitive Phone Calls
- Alzheimer's and Dementia Caregiver Training: Home Safety
- Best Practices & Emerging Therapies for Patients with Alzheimer’s Disease
- Recognizing the Early Signs of Dementia
- Effective Treatments and Prevention of Alzheimer’s Disease: The Time is Now - Research on Aging
- Dementia – it affects us all
- Falls Prevention in People with Dementia
- Caregiver Training Part I: Introduction
- Caregiver Training Part II: Hallucinations
- Caregiver Training Part III: Refusal to Bathe
- Caregiver Training Part IV: Refusal to Take Medication
- Caregiver Training Part V: Repetitive Behaviors
- Caregiver Training Part VI: Repetitive Questions
- Caregiver Training Part VII: Sundowning
- Caregiver Training Part VIII: Wandering
- The Benefits of Early Detection of Alzheimer's Disease
- A New Way To Look At Alzheimer's
- The Healing Power of Music
- Falls Prevention in People with Dementia
- Falls Prevention in People with Dementia
- Protecting & Caring for Patients with Dementia
- Dementia 101 in 101 Seconds
- Normal and Abnormal Aging and the Brain
- Alzheimer’s Disease and Parkinson’s Disease
- Aggressive Behavior in People with Dementia
- Diagnosing Alzheimer’s
- Signs of Alzheimer’s
- Practical Tips for Travelling with a Loved One with Alzheimer's Disease
-
More Information
Topics
-
Related Topic Centers
-
Addictions
-
Aging & Elder Care
-
Assessments & Interventions
-
Career & Workplace
-
Emotional Well-Being
-
Life Issues
-
Parenting & Child Care
-
Abuse
-
ADHD: Attention Deficit Hyperactivity Disorder
-
Adoption
-
Autism
-
Child & Adolescent Development: Overview
-
Child & Adolescent Development: Puberty
-
Child Development & Parenting: Early (3-7)
-
Child Development & Parenting: Infants (0-2)
-
Child Development & Parenting: Middle (8-11)
-
Child Development & Parenting:Adolescence (12-24)
-
Child Development Theory: Adolescence (12-24)
-
Child Development Theory: Middle Childhood (8-11)
-
Childhood Mental Disorders and Illnesses
-
Childhood Special Education
-
Divorce
-
Family & Relationship Issues
-
Intellectual Disabilities
-
Learning Disorders
-
Oppositional Defiant Disorder
-
Parenting
-
Self Esteem
-
-
Psychological Disorders
-
Anxiety Disorders
-
Bipolar Disorder
-
Conversion Disorders
-
Depression: Depression & Related Conditions
-
Dissociative Disorders
-
Domestic Violence and Rape
-
Eating Disorders
-
Impulse Control Disorders
-
Intellectual Disabilities
-
Mental Disorders
-
Obsessive-Compulsive Spectrum Disorders
-
Personality Disorders
-
Post-Traumatic Stress Disorder
-
Schizophrenia
-
Sexual Disorders
-
Somatic Symptom and Related Disorders
-
Suicide
-
Tourettes and other Tic Disorders
-